For in-vitro research use only. Not for human consumption.
Liraglutide
Liraglutide is a GLP-1 receptor agonist sharing 97% sequence homology with native GLP-1. Its C-16 palmitic acid modification enables non-covalent albumin binding, extending research half-life compared to native GLP-1 but shorter than Semaglutide. It activates GLP-1 receptors involved in glucose homeostasis and metabolic signaling.
Liraglutide definition
Liraglutide is a GLP-1 receptor agonist sharing 97% sequence homology with native GLP-1. Its C-16 palmitic acid modification enables non-covalent albumin binding, extending research half-life compared to native GLP-1 but shorter than Semaglutide. It activates GLP-1 receptors involved in glucose homeostasis and metabolic signaling.
No sequence is listed in the current catalog record for this product.
- CAS
- 204656-20-2
- MW
- 3751.20 g/mol
- Sequence
- Not listed
- Half-life
- Discussed in research notes
- Formula
- C172H265N43O51
- Purity
- 99.84%
- Form
- Lyophilized powder
- Class
- GLP-1 Receptor Agonist
Reconstitution calculator
Estimate vial concentration and aliquot volume from the selected vial mass, solvent volume, and target research amount.
Calculations are for lab planning only and do not replace the product COA, protocol requirements, or qualified professional review. Confirm solvent compatibility before use.
Compound details.
- CAS Number
- 204656-20-2
- Molecular Weight
- 3751.20 g/mol
- Molecular Formula
- C₁₇₂H₂₆₅N₄₃O₅₁
- Class
- GLP-1 Receptor Agonist
- Purity
- ≥99% purity
- Physical Form
- Lyophilized powder
- Storage
- Store at -20°C (long term). Refrigerate after reconstitution.
Research context.
The active ingredient in Victoza and Saxenda, Liraglutide has been studied in the LEAD and SCALE clinical trial programs. It serves as a benchmark compound for GLP-1 receptor pharmacology and metabolic signaling research.
Verification standard.
Every Nexus Laboratory batch ships with a Certificate of Analysis documenting HPLC purity (target ≥98%), mass spectrometry identity (expected versus observed mass), and endotoxin screening — verified by third-party laboratory testing and publicly archived. Review Nexus lab verification.
Liraglutide is part of the Nexus GLP-1 & Metabolic catalog. GLP-1, amylin, and multi-agonist metabolic research peptides. Each listed variant is priced from the consolidated Nexus catalog and intended for qualified research use only.
TODO-COPY: replace with real compound-specific narrative.
The chemistry.
31-amino acid GLP-1 analog with C-16 palmitic acid modification
Storage: Store at -20°C (long term). Refrigerate after reconstitution.
Technical specifications.
- Product Name: Liraglutide
- Classification: GLP-1 Receptor Agonist
- Structural Description: 31-amino acid GLP-1 analog with C-16 palmitic acid modification
- CAS Number: 204656-20-2
- Molecular Weight: 3751.20 g/mol
- Purity: ≥99% (verified by HPLC and Mass Spectrometry)
- Physical Form: Lyophilized (freeze-dried) powder
- Intended Use: In-vitro research use only — not for human consumption
HPLC trace preview.
Related research compounds
Same category, mechanism overlap, and common research stack pairings.
Liraglutide research FAQ.
What is Liraglutide used for in research?
Liraglutide is supplied for controlled in-vitro research workflows in the GLP-1 & Metabolic category. It is not labeled for human or veterinary use.
Is Liraglutide HPLC verified?
Liraglutide is listed with Nexus lab verification. Current catalog records show 99.84% purity context where batch COA data is available.
Which Liraglutide sizes are available?
Current Nexus variants include 5mg, 10mg, 30mg.
Does Liraglutide include a COA?
Yes. The current Nexus record links Liraglutide to batch NEX-LIRAGLUTIDE-2026-0048.